Call for Expression, Inactivated Polio Vaccine

The HPA hasrecently issued a Call for Expressions of Interest for licensing inactivated polio vaccine (IPV) manufacturing technology based on the use of non-pathogenic strains of polio. This has been developed by the United Kingdom’s National Institute for Biological Standards and Control (NIBSC), a Centre of the Health Protection Agency (HPA). For further information, please view the Call document Call for Expression of interest, Inactivated Polio Vaccine (PDF, 224 KB)

Full instructions on how to respond to the Call for Expressions of Interest are provided in the Call document. The deadline for the receipt of Expressions of Interest by HPA is 23 December 2011.

Correspondence in relation to this Call should be addressed to: business@hpa.org.uk.